Dopamine receptor signaling molecules are altered in elderly schizophrenic cortex
- PMID: 16786528
- DOI: 10.1002/syn.20292
Dopamine receptor signaling molecules are altered in elderly schizophrenic cortex
Abstract
Alterations of molecules that mediate dopaminergic signal transduction have been found in schizophrenia, supporting the hypothesis of altered dopaminergic neurotransmission in this illness. To further explore this hypothesis, the authors measured transcript expression of three proteins involved in dopamine (DA) signaling in postmortem dorsolateral prefrontal and anterior cingulate cortex of elderly schizophrenic subjects and a comparison group. The transcript encoding calcyon, a protein that potentiates crosstalk between D1 DA receptors and Gq/11-linked receptors, was increased in schizophrenic prefrontal and cingulate cortex by 25%. Transcript levels of spinophilin, a protein enriched in dendritic spines that modulates excitatory neurotransmission, were increased 22% in dorsolateral prefrontal cortex but were unchanged in anterior cingulate cortex in schizophrenia. Levels of DARPP-32 mRNA, a downstream effector of dopaminergic neurotransmission, were similar in both groups for both cortical groups. These alterations in spinophilin and calcyon mRNA levels in schizophrenic prefrontal and cingulate cortex provide further evidence of altered dopaminergic neurotransmission in this illness.
Copyright (c) 2006 Wiley-Liss, Inc.
Similar articles
-
Abnormalities in the dopamine system in schizophrenia may lie in altered levels of dopamine receptor-interacting proteins.Biol Psychiatry. 2004 Sep 15;56(6):427-40. doi: 10.1016/j.biopsych.2004.06.022. Biol Psychiatry. 2004. PMID: 15364041
-
Dopaminergic abnormalities in select thalamic nuclei in schizophrenia: involvement of the intracellular signal integrating proteins calcyon and spinophilin.Am J Psychiatry. 2005 Oct;162(10):1859-71. doi: 10.1176/appi.ajp.162.10.1859. Am J Psychiatry. 2005. PMID: 16199832
-
Lamina-specific abnormalities of AMPA receptor trafficking and signaling molecule transcripts in the prefrontal cortex in schizophrenia.Synapse. 2006 Dec 15;60(8):585-98. doi: 10.1002/syn.20329. Synapse. 2006. PMID: 16983646
-
Dopamine and serotonin interactions in the prefrontal cortex: insights on antipsychotic drugs and their mechanism of action.Pharmacopsychiatry. 2007 Dec;40 Suppl 1:S27-33. doi: 10.1055/s-2007-992133. Pharmacopsychiatry. 2007. PMID: 18080940 Review.
-
[DARPP-32 in the patients with endogenous psychosis].Brain Nerve. 2007 Nov;59(11):1257-63. Brain Nerve. 2007. PMID: 18044203 Review. Japanese.
Cited by
-
Dendritic spine alterations in schizophrenia.Neurosci Lett. 2015 Aug 5;601:46-53. doi: 10.1016/j.neulet.2014.11.042. Epub 2014 Dec 3. Neurosci Lett. 2015. PMID: 25478958 Free PMC article. Review.
-
Detailed DARPP-32 expression profiles in postmortem brains from patients with schizophrenia: an immunohistochemical study.Med Mol Morphol. 2011 Dec;44(4):190-9. doi: 10.1007/s00795-010-0524-1. Epub 2011 Dec 17. Med Mol Morphol. 2011. PMID: 22179181
-
Calcyon mRNA expression in the frontal-striatal circuitry and its relationship to vesicular processes and ADHD.Behav Brain Funct. 2007 Jul 10;3:33. doi: 10.1186/1744-9081-3-33. Behav Brain Funct. 2007. PMID: 17623072 Free PMC article.
-
Calcyon upregulation in adolescence impairs response inhibition and working memory in adulthood.Mol Psychiatry. 2011 Jun;16(6):672-84. doi: 10.1038/mp.2011.14. Epub 2011 Mar 15. Mol Psychiatry. 2011. PMID: 21403673 Free PMC article.
-
Genetic evidence implicating DARPP-32 in human frontostriatal structure, function, and cognition.J Clin Invest. 2007 Mar;117(3):672-82. doi: 10.1172/JCI30413. Epub 2007 Feb 8. J Clin Invest. 2007. PMID: 17290303 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
